Increased Diabetes Prevalence Due to Medical Advances
|
By HospiMedica International staff writers Posted on 17 May 2016 |
A new study has concluded that the global increase in type 1 diabetes (T1D) mellitus is directly linked to reduced natural selection resulting from improved medical care.
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Latest Critical Care News
- Inhaled Analgesic Matches Morphine for Prehospital Trauma Pain
- FDA Clears Tongue-Applied Neuromodulation System for Stroke Gait Rehabilitation
- Eye Test May Predict Return of Consciousness After Severe Brain Injury
- Medical Drone Program Improves Blood Access and Patient Survival
- AI System Enables Real-Time Sepsis Quality Assessment and Improves Adherence
- AI Detects Hidden ECG Marker of Sudden Cardiac Death
- FDA-Cleared AI Wearable Monitor Detects Opioid-Related Respiratory Risk in Hospitals
- Mitral Valve Repair Device Receives EU Approval for Functional Regurgitation
- AI Risk Score Reveals Hidden Hypertension-Related Organ Damage
- AI Tool Predicts Bronchopulmonary Dysplasia Risk in Preterm Infants
- Optical Brain Monitoring Predicts Neurodevelopmental Outcomes in Preterm Infants
- AI Tool Identifies Children With Pneumonia Requiring Hospital Care
- AI Ultrasound System Improves Safety of Blood–Brain Barrier Opening
- CE-Marked Smartphone AI Enables Autonomous Skin Cancer Assessment at Point of Care
- Handheld Optical Device Screens for Early Necrotizing Enterocolitis in Preterm Infants
- Home Blood Pressure Telemonitoring Linked to Fewer Cardiovascular Events
Channels
Artificial Intelligence
view channel
AI Trends Report Guides Responsible, Effective Healthcare Deployment
Hospitals are under growing pressure to adopt artificial intelligence tools that improve safety, efficiency, and continuity of care without compromising quality. At the same time, clinicians need clearer... Read more
Privacy-Preserving AI Protects Sensitive Information in ECG Data
Artificial intelligence applied to electrocardiography can extract more than cardiac rhythm. Algorithms can infer age, sex, race, and even identity from electrocardiogram (ECG) signals, creating privacy... Read moreSurgical Techniques
view channel
Aortic Arch Remodeling Device Improves Type I Dissection Repair
Acute DeBakey Type I aortic dissection is an emergent tear of the ascending aorta that can extend into the arch and descending thoracic aorta. Rapid ischemic complications and high early mortality make... Read more
Intravesical CAR T Therapy Shows Promise for Bladder Cancer Treatment
Bladder cancer is common and frequently recurs after initial therapy, exposing patients to repeated procedures and cumulative toxicity. High‑risk disease often progresses despite intravesical drugs or... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
Digital Heart Model Supports Targeted Ablation in Atrial Fibrillation
Atrial fibrillation is an erratic, quivering heartbeat and a leading cause of stroke. Catheter ablation is widely used to interrupt arrhythmogenic tissue, yet many patients—especially with persistent ... Read moreAI Framework Helps Clinicians Create Trustworthy Risk Prediction Tools
Artificial intelligence (AI) is increasingly used to estimate risks for conditions such as sepsis, heart disease, and cancer, yet many models remain difficult for clinicians to interpret or trust.... Read morePoint of Care
view channel
AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
Keratinocyte skin cancers, including basal cell and squamous cell carcinoma, account for a substantial share of dermatology workload in the United States and require accurate triage to guide biopsy decisions.... Read more







